Stage
No active trials
Next date
None yet
Trials
0 active
4 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Safety and efficacy of BMX-010 in topical treatment of rosacea.”In the company’s words, NCT03756389 on ClinicalTrials.gov
- Tested for
- Atopic Dermatitis (2 trials), Rosacea, Acne Vulgaris, Psoriasis
- Main trialPhase 2
- “This is an exploratory Phase 2 trial of BMX-010 in patients with Rosacea which will be conducted in two parts. Up to 210 subjects with Rosacea will be enrolled.”In the company’s words, NCT03756389 on ClinicalTrials.gov
Other drugs for Atopic Dermatitis
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Terminated | 2 Jul 2019 | Evaluation of Topical Application of BMX-010 in Subjects With Rosacea | |
| Phase 2Terminated | 31 Aug 2020 | Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. | |
| Phase 2Completed | 24 Jul 2021 | Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis | |
| Phase 2Terminated | 30 Dec 2023 | A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026